NYSE · ZVIA

Zevia PBC

$1.50 $0.00 (+0.00%) 1D After hours

Key Metrics

$107.66M
Market cap
P/E · TTM
$169.33M
Revenue · TTM
−$5.82M
Net income
EPS · TTM $-0.08
Dividend yield
Free cash flow
Beta · 1Y 0.81
EBITDA · TTM −$6.99M
Gross margin 47.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 18
    The stock moved +18.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 18
  • Jun 15
    The stock moved -14.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 15
  • Mar 27
    From its Jan 30 high, the share price fell 39%.

    Peak close $1.85 on Jan 30; trough close $1.13 on Mar 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -39%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$107.66M
Enterprise value
Shares outstanding71.8M
52-wk range$1.11 – $3.63
Avg volume · 20D412.8K
Net cash
Book value / share$0.59
IndustryBottled & Canned Soft Drinks & Carbonated Waters
ExchangeNYSE
About Zevia PBC
IPO dateJul 22, 2021
Employees91

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.64
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 47.6%
Operating -4.6%
Net -3.4%
FCF
ROE / ROIC -10.6% · -42.9%

Financial Health

Current ratio2.21
Quick ratio1.57
Debt / equity
Debt / EBITDA
Net cash
Working capital$28.88M

Cash Flow · TTM

Operating CF −$137.00K
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

2.6
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings